NCT03427632 (PVP) is a clinical trial of Bone Cements in Bone Tumor, sponsored by Assiut University.

Who is sponsoring NCT03427632?

NCT03427632 is sponsored by Assiut University.

What drugs are being tested in NCT03427632?

Interventions in NCT03427632: Bone Cements.

What condition does NCT03427632 study?

NCT03427632 studies Bone Tumor.

Is NCT03427632 still recruiting?

NCT03427632 is currently status unknown. Last updated 9 February 2018.

Last reviewed 2018-02-09 · How we verify

NCT03427632: PVP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Role of Percutaneous Vertebroplasty in Treatment of Vertebral Tumors

Status unknown Last updated 9 February 2018

What this trial tests

trial testing Bone Cements in Bone Tumor in 11 participants. Status unknown.

Timeline

1 March 2018

Primary endpoint
1 March 2019

1 March 2019

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	11
Start date	1 March 2018
Primary completion	1 March 2019
Estimated completion	1 March 2019
Sites	1 location across Egypt

Drugs / interventions tested

Bone Cements — full drug profile →

Conditions studied

Bone Tumor — all drugs for Bone Tumor →

Sponsor

Assiut University

Who can join

Adults 1 to 100, any sex, with Bone Tumor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Percutaneous vertebroplasty is a new technique to strengthen bone and reduce pain for patients with vertebral tumors

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Bone Tumor

Currently open trials in the same condition.

NCT06171282 — A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors · EARLY_PHASE1 · recruiting
NCT05779670 — Adherence to a Personalized Home Exercise Program in Patients With Bone Tumor Undergoing Lower Extremity Salvage Surgery · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03427632 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 9 February 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03427632.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing